Anaplastic Thyroid Cancer

Course Description

This is the recorded webinar of the live presentation.

Join the Endocrine Cancers SIG for a webinar on the diagnosis, surgical management, and latest therapies for anaplastic thyroid cancer.

Target Audience

The intended audience for this activity includes a wide range of health care professionals; Physician-in-practice, Fellows, Resident and anyone who may deem this presentation beneficial.

Learning Objectives

1. Describe the important tests for diagnosing and staging anaplastic thyroid cancer.
2. Identify important factors for the optimal surgical management of anaplastic thyroid cancer.
3. Describe evidence-based therapies for anaplastic thyroid cancer.

Faculty

Speakers:

Electron Kebebew, MD, FACS, Harry A. Oberhelman Jr and Mark L. Welton Professor and Chief of General Surgery, Stanford University Health
Maria Cabanillas, MD, Oncologic Endocrinologist University of Texas MD Anderson Cancer Center

Moderators:

Zeina Hannoush, MD Assistant Clinical Professor University of Miami Health System
Samira Sadowski, MD Physician-Scientist Early Investigator National Cancer Institute, Center for Cancer Research

Summary


Availability:	Retired


Cost:	Member: $0.00 Non-Member: $45.00 In-Training Member: $0.00 Resident Member: $0.00 Resident Non-Member: $45.00


Credit Offered:	No Credit Offered

Recommended

Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline Activity

Multiple Credits

FREE

(8)

Approaching the Treatment of Hypertriglyceridemia with Confidence

Multiple Credits

FREE

(9)

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline Activity

Multiple Credits

FREE

(8)


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274